A global safety analysis of minoxidil, a common hair loss treatment, revealed over 45 infant cases of excessive hair growth ...

When vision deteriorates, it's easy to dismiss it as just 'getting older.' However, it could be a sign of retinal disease, ...

“Temporary loss of vision in one eye for seconds or minutes, as if a curtain was pulled down, is known as amaurosis fugax and ...

What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

A new study in The New England Journal of Medicine revealed that the PRIMA brain computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some ...

A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of ...

This individual participant data meta-analysis aimed to determine whether time to treatment influences the effect of intraarterial thrombolysis (IAT), intravenous thrombolysis, and conservative ...

Minimally invasive cosmetic procedures can cause rare but severe ophthalmological complications, including irreversible vision loss from central retinal artery occlusion. Prevention is crucial due to ...

A recently published report associated the development of central retinal artery occlusion (CRAO) with the use of paclitaxel to treat breast cancer, reported first author Harsh H. Jain, MBBS, DNB. He ...

Regeneron Pharmaceuticals has announced the U.S. FDA's acceptance for Priority Review of the supplemental Biologics License Application for EYLEA HD (aflibercept) Injection 8 mg, which, if approved, ...

An FDA target action date of August 19, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application ...